Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across...
-
Kennewick, WA, July 27, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy™, is pleased to share this update on the meaningful...
-
Austin, July 27, 2026 (GLOBE NEWSWIRE) -- The Enterprise Browser Market was valued at USD 6.30 Billion in 2025 and is expected to reach USD 24.19 Billion by 2035, expanding at a CAGR of 14.42%. The...
-
Kennewick, WA, July 27, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy™, is pleased to share this update on the meaningful...
-
Austin, United States, July 27, 2026 (GLOBE NEWSWIRE) -- The Healthcare Technology Market was valued at USD 576.24 Billion in 2025 and is projected to reach USD 3,069.32 Billion by 2035, growing at...
-
Company expects preliminary revenue year-over-year growth of 14% for second quarter 2026 and 20% for the first half of 2026 as Aquadex Ultrafiltration platform drives continued commercial momentum ...
-
MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with...
-
NASHVILLE, Tenn., July 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its...
-
Dublin, July 24, 2026 (GLOBE NEWSWIRE) -- The "Medical Gas and Equipment Market by Type, Application, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. ...
-
CEO Discusses Why the Future of Cancer Treatment May Belong to Combination Approaches and How ERNA-101 Was Designed to Turn Immunologically "Cold" Tumors Into Targets for the Immune System Video...